Nuo Therapeutics, Inc. announced that it has engaged Winter Harbor LLC to assist the company in its financial restructuring process. In connection with the engagement, Mr. Shaun Martin, a principal at Winter Harbor, has been appointed Chief Restructuring Officer of Nuo effective December 15, 2015, and will report directly to its Board of Directors. Mr. Martin is a co-founder of Winter Harbor LLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7499 USD | -0.01% | -3.86% | +36.35% |
05-20 | Nuo Therapeutics, Inc. announced that it has received $0.650875 million in funding | CI |
05-15 | Nuo Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
+36.35% | 33.18M | |
+11.91% | 114B | |
+11.60% | 105B | |
-4.68% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-17.47% | 16.13B | |
+2.77% | 13.75B | |
+34.58% | 11.76B |
- Stock Market
- Equities
- AURX Stock
- News Nuo Therapeutics, Inc.
- Nuo Therapeutics Announces Appointment of Shaun Martin as Chief Restructuring Officer Effective December 15, 2015